SCHEMBL12894331

SCHEMBL12894331

CCc1ccc(N(C)CC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.48
ADRA2B P18089 2/20 0.48
ADRA2C P18825 2/20 0.48
ALDH1A1 P00352 2/20 0.42
TSHR P16473 2/20 0.42
MAPK1 P28482 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CYP3A4 P08684 1/20 0.42
TP53 P04637 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41
HPGD P15428 1/20 0.39
CYP2A6 P11509 1/20 0.39
LPL P06858 1/20 0.39
LIPG Q9Y5X9 1/20 0.39
CA2 P00918 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP2C9 P11712 1/20 0.36
CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10330355 0.87 ADRA2A (0.58) ADRA2AADRA2BADRA2CALDH1A1TSHR
SCHEMBL12680471 0.85 ALDH1A1 (0.61) ADRA2AADRA2BADRA2CALDH1A1TSHR
SCHEMBL6841550 0.85 ALDH1A1 (0.61) ADRA2AADRA2BADRA2CALDH1A1TSHR
SCHEMBL14905181 0.81 MAPT (0.42) ALDH1A1TSHRMAPK1TDP1CYP3A4
SCHEMBL15014122 0.81 ADRA2A (0.50) ADRA2AADRA2BADRA2CALDH1A1TSHR
SCHEMBL12679045 0.79 ALDH1A1 (0.74) ADRA2AADRA2BADRA2CALDH1A1TSHR
SCHEMBL15613386 0.79 HRH3 (0.40) ALDH1A1TSHRMAPK1TDP1CYP3A4
SCHEMBL44501 0.79 ALDH1A1 (0.67) ALDH1A1TSHRMAPK1TDP1CYP3A4
SCHEMBL17485895 0.79 CHKA (0.47) ALDH1A1TSHRMAPK1TDP1CYP3A4
SCHEMBL4400993 0.79 ADRA2A (0.52) ADRA2AADRA2BADRA2CALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3875281-A1 LITHOGRAPHIC PRINTING PLATE ORIGINAL PLATE, METHOD FOR PRODUCING LITHOGRAPHIC PRINTING PLATE AND LITHOGRAPHIC PRINTING METHOD FUJIFILM Corporation (JP) 2021-09-08 EP disclosed
EP-2900234-B1 CANCER CHEMOTHERAPEUTIC AGENT/FORMULATION, MANUFACTURE AND USE THEREOF BOSE INST (IN) 2020-10-28 EP disclosed
US-7884108-B2 tyrosine kinase inhibitors such as N-(3-(6-(4-(1,4-Dimethyl-3-oxopiperazin-2-yl)phenyl amino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-fluorophenyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamide for treating bone disorders, allergic disorders, autoimmune diseases, inflammatory diseases CGI PHARMACEUTICALS, INC. (US) 2011-02-08 US disclosed